MEGAN DURRETT: Open Payments
NPI 1972193589 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 39 payments from 9 companies in 2025. Trend: 2023 $117 · 2024 $75 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $34 |
| Corcept Therapeutics | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, QULIPTA, CAPLYTA, FANAPT, UBRELVY, Korlym, Auvelity, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
